Hypocholesterolemia in sepsis and critically ill or injured patients

Critical Care

Volumn 7, Issue 6, 2003, Pages 413-414

  Wilson, Robert F ^a   Barletta, Jeffrey F ^a   Tyburski, James G ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; HIGH DENSITY LIPOPROTEIN; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA; VERY LOW DENSITY LIPOPROTEIN;

ARTICLE; ARTIFICIAL VENTILATION; CHOLESTEROL BLOOD LEVEL; CRITICAL ILLNESS; CYTOKINE RELEASE; DISEASE COURSE; DISEASE SEVERITY; HUMAN; HYPOCHOLESTEROLEMIA; INFECTION; INJURY; INJURY SCALE; INTENSIVE CARE UNIT; NONHUMAN; NUTRITIONAL STATUS; PRIORITY JOURNAL; SEPSIS; SURGICAL PATIENT; TRANSGENIC MOUSE;

ANIMALS; CHOLESTEROL; HUMANS; INJURY SEVERITY SCORE; MICE; SEPSIS; WOUNDS AND INJURIES;

EID: 0348161256     PISSN: 13648535     EISSN: None     Source Type: Journal    
DOI: 10.1186/cc2390     Document Type: Article

References (14)

1. Dunham CM, Fealk MH, Sever WE: Following severe injury, hypocholesterolemia improves with convalescence but persists with organ failure or onset of infection. Crit Care 2003, 7: R145-R153.
2. Fraunberger P, Schaefer S, Werdan K, Walli AK, Seidel D: Reduction of circulating cholesterol and apolipoprotein levels during sepsis. Clin Chem Lab Med 1999, 37:357-362.
3. Coombes EJ, Shakespeare PG, Batstone GF: Lipoprotein changes after burn injury in man. J Trauma 1980, 20:971-975.
4. Harris HW, Grunfeld C, Feingold KR, Read TE, Kane JP, Jones AL, Eichbaum EB, Bland GF, Rapp JH: Chylomicrons alter the fate of endotoxin, decreasing tumor necrosis factor release and preventing death. J Clin Invest 1993, 91:1028-1034.
5. Tobias PS, Soldau K, Ulevitch RJ: Identification of a lipid A binding site in the acute phase reactant lipopolysaccharide binding protein. J Biol Chem 1989, 264:10867-10871.
6. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC: CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 1990, 249:1431-1433.
7. Schumann RR, Leong SR, Flaggs GW, Gray PW, Wright SD, Mathison JC, Tobias PS, Ulevitch RJ: Structure and function of lipopolysaccharide binding protein. Science 1990, 249:1429-1431.
8. Baumberger C, Ulevitch RJ, Dayer JM: Modulation of endotoxic activity of lipopolysaccharide by high-density lipoprotein. Pathobiology 1991, 59:378-383.
9. Levine DM, Parker TS, Donnelly TM, Walsh A, Rubin AL: In vivo protection against endotoxin by plasma high density lipoprotein. Proc Natl Acad Sci USA 1993, 90:12040-12044.
10. Netea MG, Demacker PN, Kullberg BJ, Boerman OC, Verschueren I, Stalenhoef AF, van der Meer JW: Low-density lipoprotein receptor-deficient mice are protected against lethal endotoxemia and severe Gram-negative infections. J Clin Invest 1996, 97:1366-1372.
11. Hubsch AP, Powell FS, Lerch PG, Doran JE: A reconstituted, apolipoprotein A-I containing lipoprotein reduces tumor necrosis factor release and attenuates shock in endotoxemic rabbits. Circ Shock 1993; 4:14-23.
12. Pajkrt D, Lerch PG, van der Poll T, Levi M, Illi M, Doran JE, Arnet B, van den Ende A, ten Cate JW, van Deventer SJ: Differential effects of reconstituted high-density lipoprotein on coagulation, fibrinolysis and platelet activation during human endotoxemia. Thromb Haemost 1997, 77:303-307.
13. Gordon BR, Parker TS, Levine DM, Saal SD, Wange JCL, Sloan BJ, Barie PS, Rubin AL: Low lipid concentrations in critical illness: Implications for preventing and treating endotoxemia. Crit Care Med 1996, 24:584-589.
14. Gordon BR, Parker TS, Levine DM, Saal SD, Wange JCL, Sloan BJ, Barie PS, Rubin AL: Relationship of hypolipidemia to cytokine concentrations and outcomes in critically ill surgical patients. Crit Care Med 2001, 29:1563-1568.